These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 36448453)

  • 1. Identification of Transthyretin Cardiac Amyloidosis Among Patients Previously Diagnosed With Hypertrophic Cardiomyopathy.
    Rowin EJ; Ruberg FL; Das G; Higgins D; Lipe WC; Bokhari N; Dehn M; Maron BJ; Maron MS
    Circ Cardiovasc Imaging; 2022 Dec; 15(12):e014938. PubMed ID: 36448453
    [No Abstract]   [Full Text] [Related]  

  • 2. Gene Silencing Therapy in Hereditary (Variant) Transthyretin Cardiac Amyloidosis: A Puzzling Case of Decreasing Pyrophosphate Uptake on Scintigraphy.
    Smiley DA; Einstein AJ; Mintz A; Shetty M; Chan N; Helmke ST; Bhatia K; Goldner K; Brannagan TH; Santana DD; Maurer MS
    Circ Cardiovasc Imaging; 2023 Aug; 16(8):e015243. PubMed ID: 37334703
    [No Abstract]   [Full Text] [Related]  

  • 3. Transthyretin Amyloid Cardiomyopathy Mimicking Hypertrophic Cardiomyopathy in an Older Patient.
    Guimarães JPA; Trigo J; Gonçalves F; Moreira JI
    Arq Bras Cardiol; 2021 Apr; 116(4):850-853. PubMed ID: 33886739
    [No Abstract]   [Full Text] [Related]  

  • 4. Serial
    Okada A; Tateishi E; Morita Y; Ohta-Ogo K; Izumi C
    Circ Heart Fail; 2023 Jan; 16(1):e009595. PubMed ID: 36541213
    [No Abstract]   [Full Text] [Related]  

  • 5. Hereditary cardiac amyloidosis associated with Pro24Ser transthyretin mutation: a case report.
    Yamamoto H; Hashimoto T; Kawamura S; Hiroe M; Yamashita T; Ando Y; Yokochi T
    J Med Case Rep; 2018 Dec; 12(1):370. PubMed ID: 30553273
    [TBL] [Abstract][Full Text] [Related]  

  • 6. False-positive bone scintigraphy denoting transthyretin amyloid in elderly hypertrophic cardiomyopathy.
    Chimenti C; Alfarano M; Maestrini V; Galea N; De Vincentis G; Verardo R; Fedele F; Frustaci A
    ESC Heart Fail; 2021 Aug; 8(4):3387-3391. PubMed ID: 34032384
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nuclear tracers for transthyretin cardiac amyloidosis: time to bone up?
    Ruberg FL; Miller EJ
    Circ Cardiovasc Imaging; 2013 Mar; 6(2):162-4. PubMed ID: 23512778
    [No Abstract]   [Full Text] [Related]  

  • 8. From hypertrophic cardiomyopathy to transthyretin amyloidosis: an unusual case and challenging diagnosis.
    Petkow-Dimitrow P; Rajtar-Salwa R; Holcman K; Kostkiewicz M; Rubiś P
    Pol Arch Intern Med; 2020 Feb; 130(2):153-154. PubMed ID: 31933485
    [No Abstract]   [Full Text] [Related]  

  • 9. Tafamidis Treatment Decreases
    Yu AL; Chen YC; Tsai CH; Chao CC; Su MY; Juang JJ; Lee MJ; Hsieh ST; Cheng MF; Lin YH
    JACC Cardiovasc Imaging; 2023 Jun; 16(6):866-867. PubMed ID: 36881423
    [No Abstract]   [Full Text] [Related]  

  • 10. Primary amyloid heart disease presenting as hypertrophic obstructive cardiomyopathy.
    Weston LT; Raybuck BD; Robinowitz M; Brinker JA; Oetgen WJ
    Cathet Cardiovasc Diagn; 1986; 12(3):176-81. PubMed ID: 3015411
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stumbling across transthyretin amyloid cardiomyopathy during diagnostic work-up for stomach cancer.
    Lee HK; Choi YS; Han EJ; Sung YE; Youn JC
    Korean J Intern Med; 2023 Mar; 38(2):273-274. PubMed ID: 36321342
    [No Abstract]   [Full Text] [Related]  

  • 12. Low-sensitivity 99mTc pyrophosphate scintigraphy for hereditary transthyretin cardiac amyloidosis with Glu112Lys genotype.
    Deng Y; Pan R; Guo Y; Wang X; Tian Z
    Eur Heart J Cardiovasc Imaging; 2024 Feb; 25(3):e115. PubMed ID: 37956103
    [No Abstract]   [Full Text] [Related]  

  • 13. State-of-the-art radionuclide imaging in cardiac transthyretin amyloidosis.
    Singh V; Falk R; Di Carli MF; Kijewski M; Rapezzi C; Dorbala S
    J Nucl Cardiol; 2019 Feb; 26(1):158-173. PubMed ID: 30569412
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Possible gastrointestinal tract involvement in hereditary transthyretin amyloidosis identified by Technetium-99m pyrophosphate scan.
    Chen J; Tang G
    J Cardiovasc Med (Hagerstown); 2023 Jun; 24(6):373-379. PubMed ID: 37115987
    [No Abstract]   [Full Text] [Related]  

  • 15. Non-invasive detection and differentiation of cardiac amyloidosis using
    Takasone K; Katoh N; Takahashi Y; Abe R; Ezawa N; Yoshinaga T; Yanagisawa S; Yazaki M; Oguchi K; Koyama J; Sekijima Y
    Amyloid; 2020 Dec; 27(4):266-274. PubMed ID: 32722948
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Native T1 and Extracellular Volume in Transthyretin Amyloidosis.
    Martinez-Naharro A; Kotecha T; Norrington K; Boldrini M; Rezk T; Quarta C; Treibel TA; Whelan CJ; Knight DS; Kellman P; Ruberg FL; Gillmore JD; Moon JC; Hawkins PN; Fontana M
    JACC Cardiovasc Imaging; 2019 May; 12(5):810-819. PubMed ID: 29550324
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diffusion Tensor Cardiovascular Magnetic Resonance in Cardiac Amyloidosis.
    Khalique Z; Ferreira PF; Scott AD; Nielles-Vallespin S; Martinez-Naharro A; Fontana M; Hawkins P; Firmin DN; Pennell DJ
    Circ Cardiovasc Imaging; 2020 May; 13(5):e009901. PubMed ID: 32408830
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monitoring of cardiac transthyretin amyloid load by [
    Minutoli F; Laudicella R; Baldari S
    Amyloid; 2022 Sep; 29(3):210. PubMed ID: 35321592
    [No Abstract]   [Full Text] [Related]  

  • 19. Interatrial septal
    Aikawa T; Maki H; Ibe T; Manabe O; Oyama-Manabe N
    J Nucl Cardiol; 2022 Feb; 29(1):363-366. PubMed ID: 34228334
    [No Abstract]   [Full Text] [Related]  

  • 20. Can echocardiography and ECG discriminate hereditary transthyretin V30M amyloidosis from hypertrophic cardiomyopathy?
    Gustavsson S; Granåsen G; Grönlund C; Wiklund U; Mörner S; Henein M; Suhr OB; Lindqvist P
    Amyloid; 2015; 22(3):163-70. PubMed ID: 26104852
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.